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1. Introduction 
In the course of our studies on the purification 
and characteristics of ribonuclease H [ 1,2] from rat 
liver (W. Roewekamp, W. S&mid, B. Benecke and 
C.E. Sekeris, manuscript in preparation) and its role 
on hormonal control of transcription, we have obser- 
ved that rifampicin and especially some of its deriva- 
tives exert a marked inhibitory action on this nuclease. 
Recently Mijlling et al. [3] have shown that a hybrid- 
ase connected with the virion of avian myeloblastosis 
virus is likewise inhibited by a rifampicin derivative. 
2. Materials and methods 
2.1. Ribonuclease H (hybridase) 
This was prepared from rat liver cytosol by a meth- 
od to be published in detail elsewhere (W. Roewekamp, 
W. Schmid, B. Benecke and C.E. Sekeris, manuscript 
in preparation). Essentially the method consists in 
preparation of a 70,000 g supernatant fraction from 
rat liver, DEAE-32 cellulose chromatography, am- 
monium sulfate precipitation, hydroxylapatite and 
phosphocellulose chromatography. Chromatography 
on phosphocellulose leads to the appearance of two 
active fractions as shown in fig. 1. 
2.2. Assay of hybridase 
The assay is based on the ability of hybridase to 
degrade the RNA moiety of DNA-RNA hybrids [ 1, 
21. DNA-RNA hybrid of which the RNA moiety is 
radioactively labelled, was prepared as described below 
and incubated with hybridase in the presence of Mn’+ 
ions (0.6 mM) in a final volume of 150 /_d for 60 min 
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at 37”. Ten pl of the inhibitor, dissolved in ethylene 
glycol-ethanol 1: 1, were added at zero time, the con- 
trols receiving the same amount of the solvent. At the 
end of the incubation period aliquots were brought on 
filter paper discs and the amount of remaining pre- 
cipitable activity was measured by dropping the filter 
papers in 5% perchloric acid and then washing with 
5% PCA, ethanol and ether as described previously 
[4] . The filter papers were then placed in scintillation 
vials filled with T-Fluor (5 g PPO, 0.2 g dimethyl- 
POPOP in 1 1 toluol) and counted in a Mark I Nuclear 
Chicago liquid scintillation counter. The radioactivity 
remaining on the filters is reversely proportional to 
hybridase activity. 
2.3. Preparation of DNA-RNA hybrid 
Heat denatured rat liver DNA was transcribed either 
with rat liver RNA polymerase B or with E. coli RNA 
polymerase. The incubation mixture was as described 
in [5], the incubation time was 60 min at 37”. At the 
end of the incubation period the mixture was treated 
with ribonuclease (5 pg/ml) to degrade free RNA. 
This treatment is not necessary when the DNA is tran- 
scribed by rat liver polymerase B which leads to an al- 
most total (over 95%) formation of hybrids. 0.5% SDS 
was then added and the mixture submitted to chroma- 
tography on Sephadex G-75 equilibrated with 0.065 
M Tris-HCl buffer pH 7.9. The fractions containing 
the DNA-RNA hybrids were collected and pooled. 
The rifampicin derivatives tested were: AF 05, AF 013 
and PR 19. 
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Fig. 1. F’hosphocellulose chromatography of hybridase from rat liver. The enzyme preparation in 0.065 M Tris-HC1 buffer, pH 7.9 
containing 1 mM mercaptoethanol and 20% v/v glycerol was passed through a phosphocellulose column, precycled and equili- 
brated with the same buffer. The column was washed and then eluted with a O-O.4 M NH&l linear gradient in the above men- 
tioned buffer. Fractions of 15 ml were collected and assayed for hybridase activity asdescribed in Methods. 
(o-o-o): Hybridase activity; (+-O--O): protein, mg/ml; ( -): (M) NH&l. 
3. Results and discussion 
As mentioned in Methods two peaks of hybridase 
activity appear after phosphocellulose chromatography, 
which we have tentatively called A and B (see fig. 1). 
Due to the fact that we are still not aware of the in- 
terrelationship between the two activities we have 
tested the action of rifampicin and its derivatives 
separately on them. The derivatives tested are AF 05, 
AF 013 and PR 19. The first two derivatives have 
been shown to inhibit the DNA-dependent RNA poly- 
merases of eukaryotes [6,7, and P. Chambon, personal 
communication] . It is evident from figs. 2 and 3 that 
both hybridase activities A and B are inhibited by the 
above mentioned substances. However AF 013 is the 
most potent of the inhibitors, completely inhibiting 
activity A at a concentration of 200 pg/ml and activi- 
ty B up to 80% at the same concentration. PR 19 
shows 50% inhibition of activity A and 30% of activi- 
ty B at a concentration of 200 /.&ml, whereas rifam- 
picin and AF 05 show only a very weak inhibitory 
action. The finding that rifampicin and its derivatives 
inhibit hybridase activity points to possible common 
structural features between the nuclease and other en- 
zymes inhibited by these substances such as the DNA- 
dependent RNA polymerases [6,7] and the reverse 
transcriptases [8] . In this context it is of interest that 
hybridase has been found connected with the virion 
of avian myeloblastosis virus [ 3] , very probably being 
a component of the reverse transcriptase and involved 
in DNA synthesis catalysed by this enzyme. Both DNA 
polymerizing activity and the hybridase are inhibited 
by rifampicin derivatives. 
Recently we have detected hybridase activity in the 
integument of blowfly larvae [9] . This enzyme is like- 
wise inhibited by AF 013. 
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Fig. 2. Inhibitory action of rifampicin and derivatives on Fig. 3. Inhibitory action of rifampicin and derivatives on 
hybridasc (activity A) fractions 22-28, (see fig. 1). hybridase (activity B) fractions 32-40 (see fig. 1). 
(o-e-0): rifampicin; (o-0-0): rifampicin; 
(a-n-~): AF 05; (a-a-a): AF 05; 
(o-o-o): AF 013; 
(x-x-x): PR 19. 
(o-o-o): AF 013; 
(x-x-x): PR 19. 
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